ASGR1 and neoplasm: One notable example is the glycosylated prodrug Gal-DOX, which incorporates a galactose moiety to facilitate selective binding to the asialoglycoprotein receptor 1 (ASGPR1), commonly overexpressed on specific tumor cells.